Fibroblast growth factor receptors as treatment targets in clinical oncology

M Katoh - Nature reviews Clinical oncology, 2019 - nature.com
FGFRs are receptor tyrosine kinases with a role in several biological processes, such as the
regulation of development and tissue repair. However, alterations in FGFRs 1–4, such as …

Fibroblast growth factor receptor signalling dysregulation and targeting in breast cancer

C Francavilla, CS O'Brien - Open Biology, 2022 - royalsocietypublishing.org
Fibroblast Growth Factor Receptor (FGFR) signalling plays a critical role in breast embryonal
development, tissue homeostasis, tumorigenesis and metastasis. FGFR, its numerous FGF …

[HTML][HTML] Fibroblast growth factor receptor 2 signaling in breast cancer

H Lei, CX Deng - International journal of biological sciences, 2017 - ncbi.nlm.nih.gov
Fibroblast growth factor receptor 2 (FGFR2) is a membrane-spanning tyrosine kinase that
mediates signaling for FGFs. Recent studies detected various point mutations of FGFR2 in …

[HTML][HTML] MRE11 as a molecular signature and therapeutic target for cancer treatment with radiotherapy

YY Wang, AC Hung, S Lo, YC Hsieh, SSF Yuan - Cancer Letters, 2021 - Elsevier
MRE11, the core of the MRE11/RAD50/NBS1 complex, is one of key DNA damage response
proteins. Increasing evidence suggests that its expression in cancer cells is critical to …

MRE11 promotes oral cancer progression through RUNX2/CXCR4/AKT/FOXA2 signaling in a nuclease-independent manner

YY Wang, YK Chen, S Lo, TC Chi, YH Chen, SCS Hu… - Oncogene, 2021 - nature.com
MRE11, the nuclease component of RAD50/MRE11/NBS1 DNA repair complex which is
essential for repair of DNA double-strand-breaks in normal cells, has recently garnered …

Matrine triggers colon cancer cell apoptosis and G0/G1 cell cycle arrest via mediation of microRNA‐22

J Liu, Y Guo, J Cao - Phytotherapy Research, 2020 - Wiley Online Library
Matrine (MAT) is an alkaloid in the dried roots of Sophora flavescens. The antitumor activity
has been testified in colon cancer. Howbeit, the latent mechanism is still indistinct. The …

DNA damage response and breast cancer development: Possible therapeutic applications of ATR, ATM, PARP, BRCA1 inhibition

M Mirza-Aghazadeh-Attari, MJ Recio, SG Darband… - DNA repair, 2021 - Elsevier
Breast cancer is the most common and significant cancers in females regarding the loss of
life quality. Similar to other cancers, one of the etiologic factors in breast cancer is DNA …

B-Myb Induces APOBEC3B Expression Leading to Somatic Mutation in Multiple Cancers

WC Chou, WT Chen, CN Hsiung, LY Hu, JC Yu… - Scientific reports, 2017 - nature.com
The key signature of cancer genomes is the accumulation of DNA mutations, the most
abundant of which is the cytosine-to-thymine (C-to-T) transition that results from cytosine …

Variants of FGFR2 and their associations with breast cancer risk: a HUGE systematic review and meta-analysis

F Cui, D Wu, W Wang, X He, M Wang - Breast cancer research and …, 2016 - Springer
Extensive epidemiological studies have demonstrated that there are associations between
variants in intron 2 of FGFR2 and the breast cancer risk in various populations; however, the …

Relationships between DNA repair and RTK-mediated signaling pathways

T Chabot, Y Cheraud, F Fleury - … et Biophysica Acta (BBA)-Reviews on …, 2021 - Elsevier
Abstract Receptor Tyrosine Kinases (RTK) are an important family involved in numerous
signaling pathways essential for proliferation, cell survival, transcription or cell-cycle …